Hi, my name is Jennifer Germain and I am a PhD student based at the Public Health Institute, Liverpool John Moores University http://www.cph.org.uk/. My PhD is looking at the use of weight loss drugs in females and I am looking for people to take part in an interview discussing their experiences. Full details are below. Thank you.
If you are female and have ever taken an unlicensed weight loss drug (Dinitrophenol, Sibutramine or Rimonabant) then we would like to hear your experiences. For the opportunity to take part in an anonymous interview please contact me at firstname.lastname@example.org.
Details of study
Research title: An exploration of the female use of unlicensed weight loss drugs Name of research and school/faculty: Jennifer Germain, PhD student, Centre for Public Health, Faculty of Health, Education and Community
What is the purpose of the study?
This research will form part of a PhD programme. Interviews will be used to discuss your experience of using weight loss drugs, your motivations for using weight loss drugs and the role of online forums in providing health information.
Do I have to take part?
No. It is up to you to decide whether or not to take part. If you do, you will be given this information sheet and asked to sign a consent form. You are still free to withdraw at any time and without giving a reason. A decision to withdraw will not affect your rights. Following the interview, there will be a ten day period where you are free to withdraw your interview from the study. However, after the interviews have been anonymised and written up, it may not be possible to withdraw your information from write up.
Why have I been selected to take part?
You have been selected to take part because you have used or are currently using an unlicensed weight loss drug. The three drugs included in this research are 2,4 Dinitrophenol (also known as DNP), Sibutramine (also known as Reductil, Meridia, Sibutrex and Slimex) and Rimonabant (also known as Acomplia). Sibutramine and Rimonabant have previously been available on prescription, we are only looking to speak to people who have used them since the drugs lost their license (Rimonabant in 2008, Sibutramine in 2010).
What will happen to me if I take part?
You will be invited to take part in an interview. The interview will last no longer than 60 minutes. We will agree a mutually convenient time, date and venue for the interview. Should a face to face interview not be feasible then we will arrange to conduct the interview by telephone or other means such as instant messenger if you would be happy with that. Prior to the interview you will be asked to read and sign a consent form and the interview will be audio recorded. The interview will follow a guide with a set of questions and you will be given the opportunity to discuss the issues at length and also to add any other information which you feel is important. You are free to leave the interview at any point should you no longer wish to take part.
Are there any risks / benefits involved?
It is possible that discussing your motivations and use of weight loss drugs could result in negative feelings. If you do become distressed during the interview and would like to stop the interview then please make the interviewer aware of this. If you would like to seek support then it is recommended that you contact Talk to Frank. To contact Talk to Frank you can visit their website: http://www.talktofrank.com/get-help, contact them by telephone: 0300 123 6600 or send a text message to 82111.
Will my taking part in the study be kept confidential?
With your permission we will digitally record the interview, whether it is conducted face to face or by telephone. Interview recordings will only be listened to by the researcher and supervisor and will be held securely at Liverpool John Moores University. Recordings will be deleted after the interview has been written up. If the interview is conducted by instant messenger then a copy of the interview will be saved. Any hard copies of data will be kept in a locked filing cabinet and electronic versions will be held on a password-protected university computer which only the research team can access. We may quote some of your words in publications and reports but to ensure that you cannot be recognised, neither your name nor any identifying features (such as forums or online communities that you use, your name or any online user names) will be included.
This study has received ethical approval from LJMU’s Research Ethics Committee Reference number 16/CPH/027
Contact Details of Researcher: Jennifer Germain, PhD student, Centre for Public Health, Liverpool John Moores University, Henry Cotton Building, 15-21 Webster Street, Liverpool, L32ET, 0151 231 4441.
Contact Details of Academic Supervisor: Jim McVeigh, Director of Centre for Public Health, Centre for Public Health, Liverpool John Moores University, Henry Cotton Building, 15-21 Webster Street, Liverpool, L32ET, 0151 231 4511.